ID
34635
Descrição
Study ID: 107434 Clinical Study ID: NAP107434 Study Title: A randomised, double-blind, double-dummy, placebo controlled, three-way cross-over study to investigate the effect of single oral doses of 100 mg GW273225 (4030W92) and 325 mg LAMICTAL on resting motor threshold in healthy subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Study Link: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GW273225 Trade Name: lamictal Study Indication: Bipolar Disorder This form contains informations about additional clinical laboratory safety tests. It should be filled out at each treatment period on admission, and on day 3, 48h00 post-dose. Screening Visit: 28 days prior to first dosing. Treatment Period: The day before dosing, until 48h after dosing. Follow-Up: 14-21 days after last dose
Palavras-chave
Versões (2)
- 03/12/2018 03/12/2018 -
- 21/01/2019 21/01/2019 -
Titular dos direitos
GlaxoSmithKline
Transferido a
21 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Effect of Lamictal on Resting Motor Threshold Study ID 107434
Clinical Laboratory Safety Tests 2
- StudyEvent: ODM
Similar models
Clinical Laboratory Safety Tests 2
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0022885 (UMLS CUI [1,2])
C1552089 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0085762 (UMLS CUI [2])
C0202274 (UMLS CUI [3])
C1552089 (UMLS CUI [1,2])
C0947611 (UMLS CUI [1,2])
C0031831 (UMLS CUI [1,2])